Leaders | High and mighty

Genomic medicines can cost $3m a dose. How to make them affordable

The treatments are marvels of innovation. Their pricing must be inventive, too

Illustration of a pair of scissors cutting into a section of DNA
Illustration: Ben Hickey

Many diseases are the result of choice or circumstance: an unhealthy way of life, toxic living conditions or a chance encounter with a virus or bacterium. Others are predestined—because they are written in the genes. Millions of people worldwide suffer from the most common genetic diseases, such as sickle-cell anaemia or thalassemia, two blood disorders. A long tail of rarer conditions each afflict an unfortunate few, who add up to many millions in total.

Chinese business goes global

From the August 3rd 2024 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

How to respond to the riots on Britain’s streets

The violence demands robust policing, but it also requires cool heads

Is the big state back in Britain?

The risk is not too much interventionism, but too little audacity



Chinese companies are winning the global south

Their expansion abroad holds important lessons for Western incumbents

The Middle East must step back from the brink

That still means starting with a ceasefire in Gaza

Can Nicolás Maduro be stopped from stealing Venezuela’s election?

Peaceful protests and judicious diplomacy offer some hope